EU Exit Planning: Non-Clinical Goods and Services

Thank you for responding to our recent survey on practice needs in the event of a no-deal Brexit. We rely on your input.
Following a discussion at our Annual General Meeting on Thursday 24 January, we asked you about the impact of a no-deal EU exit on your practice-critical Non-Clinical Goods and Services (NCGS). Medical devices, clinical consumables and medicines are being considered separately.

We asked you to consider:

  • The dependency of those goods/ services on that front-line service;
  • The criticality of that front-line service and its clinical importance; and
  • Outsourced services such as equipment maintenance.

We had a really good response and have been able to advise officials about supply concerns across London in good time. Whilst there were a number of respondents who are unconcerned about the impact of no-deal Brexit, those who do harbour concerns highlighted a number of non clinical products and services which they fear might be affected. These include:

  • Stationary;
  • Printer ink;
  • Prescription pads;
  • Couch roll;
  • Paper;
  • Telephony;
  • Cleaning products;
  • Prescription paper;
  • Printer;
  • Hand towels;
  • Testing;
  • Telephone systems;
  • Practice cleaning products; and
  • Toner.

We will continue to work with officials to identify and anticipate the impact of Brexit on London general practice, be it no-deal or otherwise. Other possible EU exit risks include: 

  • Goods or services that have supply chain touch points in the EU;
  • Personal data held in EU member countries;
  • Supply routes into the UK via Dover/ Calais; and
  • Dependencies on EU regulations.

If you have any comments or questions about this work, please contact us.

This word cloud gives some indication of respondents' concerns.

Last updated : 20 Mar 2019

 

Advice on military veterans with concerns over Mefloquine (21 Sep 2016)

Individuals who may have taken Mefloquine prescribed by the Ministry of Defence (MoD) are now being offered support from the MoD’s Single Point of Contact (SPOC) for Mefloquine, launched on...
Read more »

Capita / PCSE delays in performers list applications (21 Sep 2016)

There have been delays in processing GP trainee applications for the Performers List beyond the three month window for applications to be processed. Whatever the reason, GP trainees are not...
Read more »

London GPs amongst most influential in the UK (21 Sep 2016)

Pulse magazine’s annual list of the 50 most influential GPs in the UK was published at the start of September. In its seventh year, the Power 50 recognised Dr Michelle...
Read more »

Sustainability and Transformation Plans - September 2016 Update (21 Sep 2016)

Sustainability and Transformation Plans in London On Wednesday 14 September MPs debated concerns regarding the impact of NHS Sustainability and Transformation Plans on frontline services. Challenging both the transparency and...
Read more »

Patient engagement survey shows patients are behind us (21 Sep 2016)

Our patient engagement survey reached both practice leads and members of patient participation groups (PPGs). Responses suggest that many of the current challenges faced by general practice are on the...
Read more »

Winter planning - start encouraging flu vaccinations now (19 Sep 2016)

Practices should have received their stocks of influenza vaccine by now. We strongly advise that practices who have yet to do so, to start informing their patients who are over 65...
Read more »

Speakers' Corner - Cancer awareness at The Royal Marsden (14 Sep 2016)

This month's Speakers' Corner comes from The Royal Marsden, the world renowned hospital that specialises in cancer care, treatment, research, training and education. This month is Gynaecological Cancer Awareness month. ...
Read more »

Mword - Issue 30 (12 Sep 2016)

12 September 2016...
Read more »
Next Page »
« Previous Page